We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 17 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 5 actions collected · 5 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2026. 05. 28. | Stifel | — | Maintain | Buy → Buy | — | Stifel: Buy |
| 2026. 05. 15. | UBS | — | Maintain | Buy → Buy | — | UBS: Buy |
| 2026. 05. 06. | JP Morgan | — | Maintain | Neutral → Neutral | — | JP Morgan: Neutral |
| 2026. 05. 04. | Cantor Fitzgerald | — | Maintain | Neutral → Neutral | — | Cantor Fitzgerald: Neutral |
Past rating changes by firm, agreement/divergence within the sector, and what target changes mean.